Clinical Trial Update: Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix [NA]

View source ↗

Summary

A completed clinical trial sponsored by the University of Toronto evaluating whether herpes simplex virus type 2 therapy can reduce HIV target cell numbers in t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Herpes Simplex Infection

Drugs mentioned

• Herpes simplex virus type 2 therapy

Snippet

Sponsor: University of Toronto | Conditions: Herpes Simplex Type Two Infection, HIV Infections | NA | Status: COMPLETED